13
Jun
2018
EHA18 Preview: Blood Drugs to Watch in Stockholm
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account. 
Share:
23
May
2018
Re-Starting a Company, Keeping Hope Alive: Chip Clark on The Long Run
Today’s guest on The Long Run is Chip Clark. He’s the CEO of Cambridge, Mass.-based Genocea Biosciences. This vaccine platform company got into a jam last summer. It completed a Phase II trial with its lead therapeutic vaccine for genital herpes. Clark tried to insist the trial was a success and the product had a future. The market disagreed. The...Read More
Share:
20
Apr
2018
Harnessing What Was There All Along. Book Review of ‘A Cure Within’
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
26
Mar
2018
Mt. Everest: It’s Time
Six months of hard training is in the bank. Tomorrow morning, I will lug a pair of 120-liter gear bags to the airport and get on the plane for Kathmandu. Destination: Mt. Everest, 29,029 feet/8,848 meters. The summit of the highest mountain in the world. No matter what happens, three things are certain: I’ve given it everything I’ve got to prepare...Read More
Share:
21
Mar
2018
TCR2 Therapeutics Grabs $125M to Take TCR Therapies, Sans HLA Screens, To the Clinic
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
12
Mar
2018
Photo Gallery: The Boston Cancer Summit
What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...Read More
Share:
12
Mar
2018
Photo Gallery: The Seattle Cancer Summit
What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...Read More
Share:
8
Mar
2018
What’s Better Than Curing Cancer? Preventing It!
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Mar
2018
Getting to Precision Medicine for I-O Combinations – It’s Even More Complicated
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Feb
2018
All-Star Lineup for Boston Cancer Summit, March 7: Novartis, J&J, Third Rock, Atlas
Timmerman Report is bringing together major East Coast cancer R&D players for an intimate half-day event on March 7: the Boston Cancer Summit. Join an all-star gathering of pharma executives, hot startups, and VCs making things happen in the treatment and diagnosis of cancer. Tickets are sold out. The conference will be at Sanofi Genzyme’s flagship building in the heart of Kendall Square....Read More
Share:
15
Feb
2018
Mingle in Seattle with Genentech, Celgene, OrbiMed, 5AM & More, March 5
Exclusive Event, Powerhouse Lineup: Seattle Cancer Summit Seattle biotech events don’t get any better than this. Timmerman Report is bringing together major West Coast players for an intimate half-day event on March 5: the Seattle Cancer Summit. Tickets are limited and going fast. And all proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight...Read More
Share:
29
Jan
2018
The Boston Cancer Summit & Seattle Cancer Summit. Two Can’t-Miss Events
Cancer wasn’t that exciting to write about when I started 15 years ago. It is now. Survival rates for several forms of cancer are going in the right direction. Immunotherapy, targeted therapy, new information on genes and proteins that redefine the molecular nature of malignancy? It’s coming together. The science is bursting with creativity, and moving fast. I’m thinking and...Read More
Share:
23
Jan
2018
Leveraging June’s I-O Team at Penn, Tmunity Fetches $100M from Gilead, Parker & Ping An
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
Jan
2018
Microsoft Makes Nine-Figure Bet on Adaptive’s TCR-Antigen Map; BioNTech Hauls in $270M for 10-Drug Cancer Pipeline
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
18
Dec
2017
Walk & Talk With Me on Powell Street at #JPM18
JPM is right around the corner. You are probably packing your calendar with one-on-one meetings, programmed events, and evening receptions. So am I. But this year, I’m adding a fun new wrinkle. I’d like you to join me. Let’s start with the basics: I need to train for the Everest Climb to Fight Cancer at Fred Hutch. San Francisco has...Read More
Share:
6
Dec
2017
Obsidian Therapeutics Gets $49.5M to Bring CAR-T Dosing Under Control
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Dec
2017
“You Went to SITC and All You Got Was This TR Post? (Part 2)
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
Nov
2017
Codiak, Aspiring to Make Exosome Drugs for Cancer, Nabs $76M to March Into Clinic
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Nov
2017
Understanding Polio, Baseball and Cancer: Sometimes the “When” is as Vital as the “What”
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
26
Oct
2017
VIDEO: Climbing Mount Everest to Support Cancer Research at Fred Hutch
Hi, I’m Luke Timmerman, a biotech journalist. I’m carrying my 80-pound training backpack, up and down the hills of Seattle, for a reason. I’m training to climb Mt. Everest, the highest mountain in the world, in 2018. Why do this? Of course, I love the mountains. But mostly, I’m doing it to support the top-notch research at the Fred Hutchinson...Read More
Share:
